Agendia to Present New FLEX Study Data at ASCO 2026 Supporting NCCN Clinical Practice Guidelines in Oncology Update Recognizing MammaPrint for Guiding Anthracycline Use in Early-Stage Breast Cancer

IRVINE, Calif. & AMSTERDAM--(BUSINESS WIRE)--Agendia will present two posters highlighting how its tests provide insights into treatment response and aid therapeutic decision-making for EBC.